Literature DB >> 11122228

Systemic therapy of atopic dermatitis.

R Sidbury1, J M Hanifin.   

Abstract

Atopic dermatitis is a chronic, relapsing, inflammatory skin disease. Topical therapy is the mainstay, but patients with widespread moderate to severe atopic dermatitis may require systemic therapy. Immunosuppressants, immune response modifiers, antihistamines and antibiotics are among the classes of systemic medications frequently used to treat extensive atopic dermatitis; the indications and scientific support for the use of these and other less commonly used medications will be reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122228     DOI: 10.1046/j.1365-2230.2000.00697.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  10 in total

1.  A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice.

Authors:  M J Finberg; G L Muntingh; C E J van Rensburg
Journal:  Inflammopharmacology       Date:  2015-10-28       Impact factor: 4.473

Review 2.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.

Authors:  Farnam B Sedeh; Mattias A S Henning; Gregor B E Jemec; Kristina S Ibler
Journal:  Acta Derm Venereol       Date:  2022-08-24       Impact factor: 3.875

4.  Oral administration of SSC201, a medicinal herbal formula, suppresses atopic dermatitis-like skin lesions.

Authors:  Bo-Kyung Park; Yang-Chun Park; In Chul Jung; Seung-Hyung Kim; Jung-Eun Choi; Sunyoung Park; Jeong June Choi; Mirim Jin
Journal:  J Med Food       Date:  2014-01-29       Impact factor: 2.786

5.  Effectiveness of the Novel Herbal Medicine, KIOM-MA, and Its Bioconversion Product, KIOM-MA128, on the Treatment of Atopic Dermatitis.

Authors:  Tae Ho Chung; Tae Jin Kang; Won-Kyung Cho; Ga Young Im; Geum Seon Lee; Min Cheol Yang; Chang-Won Cho; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-01       Impact factor: 2.629

6.  Determination of Matrine in Rat Plasma after Oral Administration of Novel Korean Herbal Medicine KIOM-MA128 and Application of PK.

Authors:  Hyun-Moon Back; Byungjeong Song; Jung-Woo Chae; Hwi-Yeol Yun; Jin Yeul Ma; Kwang-Il Kwon
Journal:  J Anal Methods Chem       Date:  2015-02-16       Impact factor: 2.193

7.  Rifampicin Alleviates Atopic Dermatitis-Like Response in vivo and in vitro.

Authors:  Seung Hyun Kim; Ki Man Lee; Geum Seon Lee; Ju-Won Seong; Tae Jin Kang
Journal:  Biomol Ther (Seoul)       Date:  2017-11-01       Impact factor: 4.634

8.  Therapeutic Effects of Saline Groundwater Solution Baths on Atopic Dermatitis: A Pilot Study.

Authors:  Jisook Yoo; Ji Young Choi; Bo Young Lee; Chang Ho Shin; Jung-Won Shin; Chang Hun Huh; Jung-Im Na
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-10       Impact factor: 2.629

9.  Chrysin Inhibits TNFα-Induced TSLP Expression through Downregulation of EGR1 Expression in Keratinocytes.

Authors:  Hyunjin Yeo; Young Han Lee; Sung Shin Ahn; Euitaek Jung; Yoongho Lim; Soon Young Shin
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  New and developing therapies for atopic dermatitis.

Authors:  Tamar Hajar; João Renato Vianna Gontijo; Jon M Hanifin
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.